Charles Schwab Investment Management Inc Tenaya Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 130,192 shares of TNYA stock, worth $79,417. This represents 0.0% of its overall portfolio holdings.
Number of Shares
130,192
Previous 152,588
14.68%
Holding current value
$79,417
Previous $218,000
66.06%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding TNYA
# of Institutions
106Shares Held
48.6MCall Options Held
74.4KPut Options Held
78.4K-
Column Group LLC San Francisco, CA9.4MShares$5.73 Million12.12% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$4.11 Million0.45% of portfolio
-
Woodline Partners LP San Francisco, CA5.92MShares$3.61 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.08MShares$2.49 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$2.49 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $25.2M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...